News & Events - Press Release In 2022

Read News By Date

Cleanascite™ Employed to Determine Role of Lipids in Neutrophil Trafficking to Infection Sites

MONMOUTH JUNCTION, NJ, December 19, 2022 -- Biotech Support Group reports on an article, describing their lipid clearance sample preparation technology to help determine the role of fatty acid oxidation and mitochondrial metabolism in a cell response study of murine cell culture models of susceptibility to infection.
Read More

Journal Article Cites HemoVoid™ in Proteomic Study of COPD

MONMOUTH JUNCTION, NJ, November 29, 2022 -- Biotech Support Group reports on a research article describing the simplicity and efficiency of their hemoglobin depletion technology for enriching erythrocyte proteins, in order to assess proteomic differences associated with COPD by LC-MS analysis.
Read More

Nature Article Cites AlbuSorb™ for Analysis of Intestinal Organoids in Crohn’s Disease

MONMOUTH JUNCTION, NJ, October 11, 2022 -- Biotech Support Group reports on a Nature article showing the use of AlbuSorb™ for immunoblotting of intestinal organoid supernatants.
Read More

Research Article Cites Viraffinity™ in Study of Viral Encephalitis

MONMOUTH JUNCTION, NJ, September 13, 2022 -- Biotech Support Group reports on a new research article describing the simplicity and efficiency of their virus enrichment technology for Sindbis virus (SINV) expressed in cell culture.
Read More

Journal Article Cites HemoVoid™ in Proteomic Study of Aging

MONMOUTH JUNCTION, NJ, September 9, 2022 -- Biotech Support Group reports on a research article describing the simplicity and efficiency of their hemoglobin depletion technology for enriching blood cell proteins in rhesus monkeys, in order to assess proteomic differences associated with aging by LC-MS analysis.
Read More

Cleanascite™ Employed to Help Determine Role of Lipogenesis in Pulmonary Arterial Hypertension

MONMOUTH JUNCTION, NJ, August 29, 2022 -- Biotech Support Group reports on an article, describing the simplicity and efficiency of their lipid clearance sample preparation technology to help determine the role of lipogenesis in a cell response study of pulmonary arterial vascular smooth muscle cells.
Read More

Journal Article Highlights HemogloBind & AlbuVoid™ to Study Protein Organization in Red Blood Cells

MONMOUTH JUNCTION, NJ, August 28, 2022 -- Biotech Support Group reports on a recent journal article highlighting the simplicity and efficiency of their Hemoglobin and Albumin depletion sample preparation technology for studying the organization of the red cell proteome by LC-MS.
Read More

Cleanascite™ Employed to Help Detect Tuberculosis Virulence Factors In Serum

MONMOUTH JUNCTION, NJ, June 24, 2022 -- Biotech Support Group reports on an article, describing the simplicity and efficiency of their lipid clearance sample preparation technology to improve a nanopore sensor peptide signature in order to identify and detect target peptides derived from two Mycobacterium tuberculosis (Mtb) virulence factors in serum.
Read More

Biotech Support Group introduces new product information and presents poster at the ASMS 2022 Conference on Mass Spectrometry & Allied Topics

MONMOUTH JUNCTION, NJ, June 22, 2022 -- Biotech Support Group presented new uses for its products in LC-MS analysis, and presented a poster with research collaborators at the ASMS 2022 Conference, in Minneapolis MN, June 5-9, 2022.
Read More

Journal Article Cites HemoVoid™ in Proteomic Study of JAK mutation and cardiovascular risk

MONMOUTH JUNCTION, NJ, May 24, 2022 -- Biotech Support Group reports on a research article describing the simplicity and efficiency of their hemoglobin depletion technology for enriching red cell proteins, in order to assess the proteomic differences associated with a JAK mutation relative to normal controls.
Read More

Journal Article Cites HemoVoid™ in Proteomic Study of Schizophrenia

MONMOUTH JUNCTION, NJ, May 20, 2022 -- Biotech Support Group reports on a research article describing the simplicity and efficiency of their hemoglobin depletion technology for enriching blood proteins, in order to profile the proteome of schizophrenia patients relative to normal controls.
Read More

Journal Article Describes HemogloBind™ For Improved Cytokine Analysis

MONMOUTH JUNCTION, NJ, May 19, 2022 -- Biotech Support Group reports on a research publication describing the simplicity and efficiency of their hemoglobin depletion products for cytokine/chemokine immunoassay measurements.
Read More

Cleanascite™ Employed to Investigate Lipid Influence in Macrophage Maturation in Cancer

MONMOUTH JUNCTION, NJ, March 9, 2022 -- Biotech Support Group reports on an article, describing the simplicity and efficiency of their lipid clearance technology for depletion of lipids in monocyte cultures prepared with supernatants from cancer cell lines.
Read More

Cleanascite™ Employed to Investigate Lipid influences in Melasma

MONMOUTH JUNCTION, NJ, February 8, 2022 -- Biotech Support Group reports on an article, describing the simplicity and efficiency of their lipid clearance sample preparation technology for studying the influence of lipids in Melasma using co-cultures with skin explants.
Read More

Journal Article by Leiden University Medical Center and Biotech Support Group Describes a Gene Signature Ratio that Predicts Survival in Colon Cancer

MONMOUTH JUNCTION, NJ, January 10, 2022 -- Biotech Support Group (BSG) and Leiden University Medical Center (LUMC), Leiden, The Netherlands, announce publication of a journal article in the publication Cancers. It is based upon on their joint goal to correlate BSG’s patent pending Stroma Liquid Biopsy™ panel of blood-borne biomarkers, to tissue derived tumor-stroma ratio (TSR) scoring methods developed by LUMC.
Read More

News & Events - Press Release In 2022

Company

Support